Collateral / Parallel Damage in Breast Cancer Treatment

“Collateral damage” in cancer treatment is a topic familiar to Dr. Susan Love but one many people have not yet heard of. Dr. Love, a surgeon specializing in breast cancer and president of a research foundation bearing her name, learned much about the consequences of cancer treatment. At the American Society of Breast Surgeons’ 2016 annual meeting, she told participants, “What drove me to examine ‘collateral damage’ in cancer treatment was my experience.”
“Three and a half years ago I was diagnosed with acute myeloid leukemia. That was when I understood the difference between surgeon and patient (the person treating and the person being treated). When you are a doctor, you have a certain perspective on events. When you move to the other side of the stage, the view is completely different,” says Dr. Love.
After a bone marrow transplant from her sister, Dr. Love’s health is very good. However, this experience gave her a new perspective. “The most important thing I learned from this experience was that doctors and patients look at events from different angles and, frankly, being the doctor is better.”
“When you are a doctor, you compare your patient with other patients who have died and congratulate yourself because your patient is improving,” says Dr. Love. “But if you are the patient, you compare yourself with how you were before and think you are here as a price you have paid. Your frame of reference is entirely different.”
During her illness, Dr. Love noticed that her doctor was not concerned with “collateral damage” such as chemo brain (thinking and memory problems that may occur after cancer treatment) and neuropathy (damage particularly to nerves at the ends of the hands and feet). Her doctor had stated that they preferred not to concern themselves with conditions they did not know how to treat.
What Is Collateral Damage?
In her presentation to colleagues, Dr. Love highlighted certain side effects that may be permanent. Collateral (accompanying, parallel) damage can be much more serious than conventional side effects, she explained: “It is as if you have had a car accident. You can get your car repaired, but its door no longer closes properly as before. When you have cancer, you continue living too, but that life may never be the same as before.”
Dr. Love emphasizes, “This does not mean patients would not make the same treatment choice again. But they need to know the potential consequences they will face and how treatment will affect their lives. Doctors need to avoid covering up these effects or acting as if they will be milder than they are.”
“The healthcare system is partly to blame,” she adds. The system is structured within itself. Patients see several specialists who are not fully coordinated and receive information at a time when they already struggle to grasp the situation. “They are already very frightened and say ‘yes’ to everything,” she says, depicting the situation based on her own experience.
The Collateral Damage Project
In August 2013, the Dr. Susan Love Research Foundation emailed thousands of participants making up the foundation’s “Army of Women” to ask open-ended questions about side effects they encountered during breast cancer treatment. Within 24 hours, the result was more than 1100 responses. “We had definitely touched a raw nerve. This was worth following up,” Dr. Love comments.
The participants’ intense interest prompted researchers to conduct larger studies. Many breast cancer support organizations surveyed their own members. Subsequently, from 3200 people with a history of breast cancer, the collateral damage project received more than 9000 questions.
Dr. Love said the findings showed breast cancer survivors struggling with chronic fatigue ([unreadable in source]), memory problems / chemo brain ([unreadable in source]), numbness in hands and feet ([unreadable in source]), anxiety / depression ([unreadable in source]), sexual problems ([unreadable in source]), lymphedema (8%), joint / bone and other pain (5%), permanent hair loss (2%) and other problems (2%). These were expected results. However, the striking point was that most participants said they did not remember being warned about these possible conditions. Dr. Love adds, “We often explain treatment side effects and consequences, but we do it when women cannot hear us, and afterward patients are surprised.”
Often the Issue Is Communication
Dr. Love and her team moved to a larger study to better measure collateral damage and developed, as part of the foundation’s ongoing “Health of Women Study,” a quality of life questionnaire. The questionnaire consisted of a series of questions designed to measure health-related complaints. It was administered to women both with and without a history of breast cancer.
So far, data from women who previously had breast cancer, numbering 12,171 within a total of 42,694 women, have produced 10 datasets compiled from their experiences. Quality-of-life data are available for 11,943 participants.
“Most of the issues mentioned relate to communication,” Dr. Love notes. For example, “I met the doctors who would treat me and they told me things, but I did not really understand what they said and was afraid to ask.” According to the study, postoperative complaints in 1000 women undergoing breast cancer surgery (lumpectomy, mastectomy, bilateral/two-sided mastectomy) were swelling or edema (13%–16%), localized physical weakness (8%–12%), back pain (19%–24%), lymphedema (13%–17%), changes in sexual desire (35%–48%), mood changes (17%–21%), depression (35%–41%) and anxiety (30%–44%).
Dr. Love noticed that many complaints occurred at similar rates regardless of the operation performed. “I found this interesting. Women requesting bilateral mastectomy because they thought it would reduce worry and anxiety were found to experience more worry and anxiety than women choosing other operations. Depression and changes in sexual desire were found to be greater in the bilateral mastectomy group.”
“Work and financial concerns were also important for many women. For example, 2 participants reported difficulty covering expenses,” Dr. Love said, emphasizing that these issues were rarely discussed.
The Next Step
The next step will be to organize and examine the data and focus on metastatic (stage 4) disease. Dr. Love will also address using the correct treatment approaches to identify patients who may be prone to particular damage such as neuropathy.
In conclusion, as Dr. Susan Love emphasizes, the aim of cancer medicine until now was mostly to keep patients alive. However, thanks to advances in cancer treatment and specialists’ growing knowledge and experience, our patients now live much longer, and damage experienced after treatment is a topic requiring more attention. Simply “curing” is not enough. After curing patients, we also need to be concerned with what their lives are like. Collateral damage after treatment is an important part of this.
Sources
Ayrıca: Love S. Collateral damage of breast cancer treatment. 2016 American Society of Breast Surgeons Annual Meeting. General Session. Presented April 15, 2016.
Was this article helpful?
Your feedback helps us improve our content.





Reader comments
Share your comment
Your name and comment are published only after administrator approval. Your email address is never shown to visitors.
Be the first to comment.